Abstract
Prostate cancer is one of the neoplasms that most affects the male population in Brazil and worldwide, which classifies it a serious public health problem. Abiraterone stands out among the most promising antineoplastics drugs due to its efficacy and control of adverse effects compared to other agents. However, despite numerous clinical advantages, abiraterone, like other chemotherapeutic …